TY  - GEN
AU  - Hong,Soon Jun
AU  - Kim,Sung Tae
AU  - Kim,Tae-Jin
AU  - Kim,Eun-Ok
AU  - Ahn,Chul-Min
AU  - Park,Jae Hyoung
AU  - Kim,Je Sang
AU  - Lee,Kyung-Mi
AU  - Lim,Do-Sun
TI  - Cellular and molecular changes associated with inhibitory effect of pioglitazone on neointimal growth in patients with type 2 diabetes after zotarolimus-eluting stent implantation
SN  - 1524-4636
PY  - 2010///1221
KW  - Adult
KW  - Aged
KW  - Angioplasty, Balloon, Coronary
KW  - adverse effects
KW  - Biomarkers
KW  - blood
KW  - Blood Glucose
KW  - metabolism
KW  - Cardiovascular Agents
KW  - administration & dosage
KW  - Cell Movement
KW  - drug effects
KW  - Cell Proliferation
KW  - Cells, Cultured
KW  - Chemokine CCL2
KW  - Coronary Angiography
KW  - Coronary Artery Disease
KW  - Coronary Restenosis
KW  - etiology
KW  - Coronary Vessels
KW  - diagnostic imaging
KW  - Diabetes Mellitus, Type 2
KW  - Dose-Response Relationship, Drug
KW  - Drug-Eluting Stents
KW  - Female
KW  - Glycated Hemoglobin
KW  - Humans
KW  - Hyperplasia
KW  - Hypoglycemic Agents
KW  - therapeutic use
KW  - Inflammation Mediators
KW  - Insulin
KW  - Interleukin-6
KW  - Killer Cells, Natural
KW  - Lipids
KW  - Male
KW  - Middle Aged
KW  - Myocytes, Smooth Muscle
KW  - Pioglitazone
KW  - Prospective Studies
KW  - Prosthesis Design
KW  - Receptors, CCR2
KW  - Republic of Korea
KW  - Single-Blind Method
KW  - Sirolimus
KW  - Thiazolidinediones
KW  - Time Factors
KW  - Treatment Outcome
KW  - Tunica Intima
KW  - Ultrasonography, Interventional
N1  - Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1161/ATVBAHA.110.212670
ER  -